Urosource: Today's Key Article

Urosource Newsletter

Poll

Home > Today's Key Article

Today's Key Article

Conference Reports

Dietary supplements discouraged for PCa patients

Edited by: ES

Wednesday, 10 March 2010- Prostate-specific dietary supplements should not be taken during radiation therapy treatments because they have been shown to increase the radiosensitivity of normal prostate cell lines, leading to normal tissue complications, according to a study in the March issue of the...

Interactive

UV light exposure lowers kidney cancer risk in men

Tuesday, 9 March 2010- Men who work in the sun are less likely to contract kidney cancer than men who work indoors, according to a study which examined more than 2,500 people in Europe.

"To our knowledge, this is the first case-control study to provide evidence of an inverse association...

Edited by: JV

BENEFIT: belatacept preserves kidneys, avoids toxicity

Monday, 8 March 2010- The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.

The results are published in...

Edited by: ES

More key articles

Circulating endothelial cells and progenitors: potential RCC biomarkers

Friday, 5 March 2010- A group of Australian researchers compared the levels of circulating endothelial cells (CECs) and progenitors (CEPs) between tumour-bearing mice and healthy controls, in human renal cell carcinoma (RCC) xenograft models.

B. Namdarian and colleagues said they also aimed...

Large kidneys predict poor renal outcome in diabetic patients with chronic renal disease

Friday, 5 March 2010- Renal hypertrophy occurs early in diabetic nephropathy, its later value is unknown. V. Rigalleau and colleagues examined the query whether large kidneys still predict poor outcome in patients with diabetes and Chronic Kidney Disease (CKD). They published their findings...

More headline news

Cystoscopy is sufficient and cost-effective to detect bladder cancer recurrence

Monday, 8 March 2010- Researchers from the University of Texas M. D. Anderson Cancer Center, USA, found that cystoscopy, the standard for screening for recurrence of early-stage bladder cancer, is a cost-effective method of detecting tumours.

Adding other tests to cystoscopy increases the cost,...

PCA3 may pick up prostate cancers before biopsy in high-risk men

Monday, 8 March 2010- The Prostate Cancer Gene 3 (PCA3) test score at the time of a negative first biopsy predicted a positive rebiopsy two years later with 79.1% specificity and 36.4% sensitivity, according to retrospective analysis of a clinical trial to be reported at the Genitourinary Cancers...

More conference reports

Role of mechanical simulators for training of laparoscopic surgery

Friday, 19 February 2010- Low fidelity simulators will play an important role in the future with regards to laparoscopic surgical training in urology, according to Prof. Jens Rassweiler (Heilbronn, Germany), director of the hands-on training in laparoscopy offered during the recently concluded 19th...

Davos: Tips and tricks on open, laparoscopic and robot-assisted radical prostatectomy

Thursday, 18 February 2010- Tips and tricks on radical prostatectomy (RP) for open, laparoscopic and robot-assisted surgeries were discussed and closely examined during the last session of the 19th European Urology Forum which ended yesterday in Davos, Switzerland.

Prof. Manfred Wirth...

7th ESOU Meeting in Vienna to tackle emerging treatment options

Friday, 8 January 2010- Emerging treatment options that impact on the diagnosis of uro-genital cancers will be examined at the annual meeting of the EAU Section of Oncological Urology (ESOU) to be held in Vienna, Austria from January 15 to 17, 2010.

Prof. Bob Djavan, chairman of the 7th ESOU...

2nd EMUC to reach new heights of international cooperation

Thursday, 26 November 2009- Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is a result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next...